Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA4 | P22748 | 2/20 | 0.59 |
| ▸ | CA6 | P23280 | 2/20 | 0.59 |
| ▸ | CA7 | P43166 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MYC | P01106 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27750587 | 0.86 | KDM4E (0.53) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL10950465 | 0.85 | CA12 (0.61) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL850741 | 0.83 | TYR (0.61) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL5813467 | 0.83 | KDM4E (0.59) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL8534552 | 0.83 | CA12 (0.59) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL9346007 | 0.83 | CA12 (0.59) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL487507 | 0.83 | HSP90AA1 (0.62) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL30019444 | 0.83 | KDM4E (0.59) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL4156373 | 0.83 | PKM (0.58) | KDM4EMAPTGAACA12CA1 | |
| SCHEMBL2755400 | 0.83 | ALDH1A1 (0.56) | KDM4EMAPTGAACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109233954-B | Energy-saving type wear-resistant hydraulic oil | 虎牌石油（中国）有限公司 | 2021-07-20 | — | — | CN | claimed |
| EP-4245830-B1 | LUBRICANT BASE OIL | KAO CORP (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-12098341-B2 | Lubricant base oil | KAO CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20230383208-A1 | LUBRICANT BASE OIL | KAO CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| CN-115667470-B | Lubricating base oil | 花王株式会社 | 2023-10-20 | — | — | CN | disclosed |
| EP-4245830-A1 | LUBRICANT BASE OIL | Kao Corporation (JP) | 2023-09-20 | — | — | EP | disclosed |
| US-20230265055-A1 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | OXFORD FINANCE LLC | 2023-08-24 | — | — | US | disclosed |
| WO-2022102651-A1 | LUBRICANT BASE OIL | 花王株式会社 | 2022-05-19 | — | — | WO | disclosed |
| CN-109233954-B | Energy-saving type wear-resistant hydraulic oil | 虎牌石油（中国）有限公司 | 2021-07-20 | — | — | CN | disclosed |
| CN-109233953-B | Flame-resistant degradation environment-friendly hydraulic oil | 虎牌石油（中国）有限公司 | 2021-07-06 | — | — | CN | disclosed |
| CN-101146530-A | 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension | NOVARTIS AG (CH) | 2008-03-19 | — | — | CN | disclosed |
| CN-101115715-A | Pyrrolidine derivatives for the treatment of diseases associated with renin activity | NOVARTIS AG (CH) | 2008-01-30 | — | — | CN | disclosed |
| EP-1863477-A1 | 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION | Novartis AG (CH) | 2007-12-12 | — | — | EP | disclosed |
| WO-2006100036-A1 | 3, 4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION | NOVARTIS AG (CH) | 2006-09-28 | — | — | WO | disclosed |
| CN-1117092-C | Azabicyclo compounds, pharmaceutical compositions and medical uses thereof | PFIZER PROD INC (US) | 2003-08-06 | — | — | CN | disclosed |
| CN-1305477-A | Azablicyclic 5-HT, receptor ligands | PFIZER PROD INC (US) | 2001-07-25 | — | — | CN | disclosed |
| WO-1995004046-A1 | COMPOUNDS AS PDE IV AND TNF INHIBITORS | RHONE-POULENC RORER LIMITED (GB) | 1995-02-09 | — | — | WO | disclosed |
| US-3985797-A | Hydroxylation of aromatic compounds | UOP INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3985796-A | Hydroxylation of aromatic compounds | UOP INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3931295-A | Hydroxylation of aromatic compounds | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265055-A1 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | STAT5B, STAT5A, STAT3 | KDM4E 2049/4885MAPT 4421/4885GAA 2407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.